الملخص

Objectives: This study aimed to assess the correlation between the severity of the initial chest x-ray (CXR) abnormalities in patients with a confirmed diagnosis of COVID-19 and the final outcomes. Methods: This retrospective study was conducted at the Royal Hospital, Oman between mid-March and May 2020 and included patients who had been admitted with a confirmed diagnosis of COVID-19 and had a final outcome. Serial CXRs were identified and examined for presence, extent, distribution and progression pattern of radiological abnormalities. Each lung field was divided into three zones on each CXR and a score was allocated for each zone (0 is normal and 1–4 is mild–severe). The scores for all six zones per CXR examination were summed to provide a cumulative chest radiographic score (range: 0–24). Results: A total of 64 patients were included; the majority were male (89.1%) and the mean age was 50.22 ± 14.86 years. The initial CXR was abnormal in 60 patients (93.8%). The most common finding was ground glass opacity (n = 58, 96.7%) followed by consolidation (n = 50, 83.3%). Most patients had bilateral (n = 51, 85.0%), multifocal (n = 57, 95.0%) and mixed central and peripheral (n = 36, 60.0%) lung abnormalities. The median score of initial CXR for deceased patients was significantly higher than recovered patients (17 versus 11; P = 0.009). Five CXR evolution patterns were identified: type I (initial radiograph deteriorates then improves), type II (fluctuate), type III (static), type IV (progressive deterioration) and type V (progressive improvement). Conclusion: A higher baseline CXR score is associated with higher mortality rate and poor prognosis in those with COVID-19 pneumonia.

بيانات النشر

المعرّف الرقمي
10.18295/squmj.4.2021.061
المجلة
مجلة جامعة السلطان قابوس الطبية, 22(1), 98-105
الناشر
جامعة السلطان قابوس
وصول مفتوح
وصول مفتوح ذهبي
الترخيص
CC BY-ND 4.0

اقتبس هذه المقالة

APA 7

Al Umairi, R. S., Al-Salmi, I., Al Kalbani, J., Kamona, A., Al Tai, S., Al Kindi, F., Jose, S., Khamis, F., Al Khalili, H., & Al Busaidi, M. (2025). COVID-2019 Pneumonia. Sultan Qaboos University Medical Journal, 22(1), 98-105. https://doi.org/10.18295/squmj.4.2021.061

MLA 9

Al Umairi, Rashid S., et al. "COVID-2019 Pneumonia." Sultan Qaboos University Medical Journal, vol. 22, no. 1, 2025, pp. 98-105. https://doi.org/10.18295/squmj.4.2021.061.

شيكاغو (المؤلف–التاريخ)

Al Umairi, Rashid S., Ishaq Al-Salmi, Jokha Al Kalbani, Atheel Kamona, Saqar Al Tai, Faiza Al Kindi, Sachin Jose, Faryal Khamis, Huda Al Khalili, and Mohammed Al Busaidi. 2025. "COVID-2019 Pneumonia." Sultan Qaboos University Medical Journal 22 (1): 98-105. https://doi.org/10.18295/squmj.4.2021.061.

هارفارد

Al Umairi, R. S., Al-Salmi, I., Al Kalbani, J., Kamona, A., Al Tai, S., Al Kindi, F., Jose, S., Khamis, F., Al Khalili, H. and Al Busaidi, M. (2025) 'COVID-2019 Pneumonia', Sultan Qaboos University Medical Journal, 22(1), pp. 98-105. doi:10.18295/squmj.4.2021.061.

فانكوفر

Al Umairi RS, Al-Salmi I, Al Kalbani J, Kamona A, Al Tai S, Al Kindi F, et al. COVID-2019 Pneumonia. Sultan Qaboos University Medical Journal. 2025;22(1):98-105. doi:10.18295/squmj.4.2021.061

IEEE

R. S. Al Umairi, I. Al-Salmi, J. Al Kalbani, A. Kamona, S. Al Tai, F. Al Kindi, S. Jose, F. Khamis, H. Al Khalili, and M. Al Busaidi, "COVID-2019 Pneumonia," Sultan Qaboos University Medical Journal, vol. 22, no. 1, pp. 98-105, 2025, doi: 10.18295/squmj.4.2021.061.